Sandoz Group AG (SDZNY) ADR Each Representing 1 Ord Share SPON

Sell:$47.87Buy:$47.87$1.17 (2.51%)

Prices delayed by at least 15 minutes
Sell:$47.87
Buy:$47.87
Change:$1.17 (2.51%)
Prices delayed by at least 15 minutes
Sell:$47.87
Buy:$47.87
Change:$1.17 (2.51%)
Prices delayed by at least 15 minutes

Company Information

About this company

Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.

Key people

Richard Saynor
Chief Executive Officer
Remco Steenbergen
Chief Financial Officer
Francisco Ballester
President, International
Rebecca Guntern
President, Europe
Keren Haruvi
President, North America
Claire D'Abreu-Hayling
Chief Scientific Officer
Ingrid Sollerer
Chief Compliance Officer, Group General Counsel
Pierre Bourdage
Chief Commercial Officer
Glenn A. Gerecke
Chief Manufacturing and Supply Officer
Tripti Jha
Chief People Officer
Gilbert Ghostine
Non-Executive Independent Chairman of the Board
Karen J. Huebscher
Non-Executive Independent Vice Chairman of the Board
Mathai Mammen
Director
Graeme David Pitkethly
Director
Michael Rechsteiner
Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Switzerland
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    US7999261008
  • Market cap
    $0.00
  • Employees
    23,848
  • Shares in issue
    440.00m
  • Exchange
    SIX Swiss Exchange
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.